Science Center

Science Center is an accelerator based in Philadelphia, Pennsylvania, established in 1963. It fosters entrepreneurial activity and healthcare innovation by facilitating the commercialization of technology and promoting regional economic development. The organization brings together scientists, entrepreneurs, funding sources, laboratory facilities, and business services to enhance the availability of life-changing scientific breakthroughs. With a focus on the pharmaceuticals and biotechnology sectors, Science Center plays a vital role in supporting the growth of life sciences and technology companies, ultimately contributing to the advancement of healthcare and economic growth in the region.

Heath Naquin

Vice President Government and Capital Engagement

14 past transactions

Taurus Vascular

Non Equity Assistance in 2023
Taurus Vascular is a medical device company dedicated to enhancing long-term outcomes for patients suffering from aortic aneurysms. The company is focused on transforming the standard of care by developing innovative medical device technology aimed at addressing the complications associated with endoleaks. This technology is designed to facilitate accelerated shrinkage of the aneurysm sac following endovascular aortic aneurysm repair (EVAR). By improving the effectiveness of treatment, Taurus Vascular aims to significantly enhance patient outcomes in the healthcare sector.

AB Fertitlity

Pre Seed Round in 2023
AB Fertitlity develops products for reproductive medicine.

EmpiricaLab

Pre Seed Round in 2023
EmpiricaLab is a developer of an online learning platform tailored for healthcare teams, emphasizing peer learning and collaborative knowledge sharing. The platform facilitates the discovery, creation, and curation of work-relevant learning content, providing a work-integrated learning curriculum that enhances onboarding and productivity. By enabling healthcare teams to collaboratively author and transfer knowledge, EmpiricaLab supports clients in accelerating digital transformation within their organizations. The company's focus on last-mile training and team-centric authoring makes it a reliable resource for improving workforce skills and effectiveness in the healthcare sector.

MTDS Solution

Pre Seed Round in 2023
MTDS Solution is a company focused on enhancing health and wellness through innovative service offerings. It provides resources aimed at reducing the operational burden on medical institutions while also serving the broader community. The company has developed fully automated kiosks for polymerase chain reaction (PCR) testing, which streamline the testing process for various health concerns. These kiosks enable patients to conduct a wide range of tests, including those for influenza, sexually transmitted infections, blood-borne pathogens, genetic conditions, and drug use. The integration of these kiosks with a user-friendly mobile application further supports patients in managing their health effectively and conveniently.

Steradian Technologies

Seed Round in 2023
Steradian Technologies is a biotech company focused on developing innovative, noninvasive diagnostic solutions for infectious diseases. The company has created a rapid COVID-19 detection test that delivers results in just 30 seconds by utilizing a unique focal point projection system that emulates human eyesight. This advanced technology employs photonics to identify pathogens in breath samples, bypassing the need for traditional laboratory equipment and lengthy procedures. By offering a portable diagnostic method that achieves high accuracy in detecting bacteria, viruses, and biomarkers, Steradian Technologies aims to transform patient care and enable clinicians to provide quicker, more precise diagnoses.

Prana Thoracic

Non Equity Assistance in 2023
Prana Thoracic, Inc., based in Houston, is a medical device startup focused on developing innovative solutions for the early intervention of lung cancer, the leading cause of cancer-related deaths in the United States. The company aims to address the critical challenges in lung cancer screening and diagnosis, where only a small percentage of cases are detected at an early stage. Prana Thoracic's advanced electrosurgical instrument utilizes bipolar radiofrequency energy to perform minimally invasive procedures, enabling physicians to capture and diagnose small, hard-to-reach lung nodules while reducing the risk of complications. By enhancing the tools available for surgical oncology in lung cancer, Prana Thoracic seeks to improve patient outcomes and capitalize on recent advancements in screening guidelines, ensuring early intervention opportunities are not missed.

BioCurie

Pre Seed Round in 2023
BioCurie is developing an artificial intelligence software platform to better cell and gene therapy.

Trace Orthopedics

Seed Round in 2023
Trace Orthopedics specializes in the development of innovative medical devices for tendon reattachment without the need for traditional surgery. The company has created a minimally invasive procedure that utilizes a specialized device designed to repair partially torn tendons by inserting a needle through the skin. This technique allows for the secure attachment of tendons back to bone, eliminating the need for general anesthesia or an operating room visit. As a result, patients benefit from quicker recovery times and reduced healthcare costs. Trace Orthopedics aims to enhance patient outcomes and streamline the treatment process in orthopedic care.

Rubitection

Seed Round in 2023
Rubitection Inc., founded in 2010 and based in Pittsburgh, Pennsylvania, specializes in developing tools for early skin health assessment and management. Their primary product is the Rubitect Assessment System, which aids caregivers, doctors, and nurses in detecting early signs of bedsores on an individual's skin. The company's mission is to establish a global standard system for monitoring and managing skin health, particularly focusing on wound care, dermatology, and cosmetics. Rubitection's handheld device is designed to be low-cost and easy to use, enabling anyone to monitor their skin health and identify conditions such as bedsores, diabetic foot ulcers, vascular leg ulcers, and chronic dermatological conditions early. The device includes features like risk analytics, remote monitoring, care plan management, and severity progression monitoring to assess tissue health effectively.

Aware.ai

Pre Seed Round in 2023
Aware.ai uses AI to create virtual support communities for women and connect them to resources during pregnancy.

Opal HTM

Seed Round in 2022
Opal HTM is a technology company focused on enhancing hospital safety and operational efficiency. It specializes in transforming medical equipment management by employing innovative technologies. The company's core offering is an advanced platform designed to optimize healthcare equipment inventory, maximizing return on investment through improved procurement and maintenance strategies. This solution empowers healthcare managers to achieve unprecedented clarity and efficiency in their equipment inventory management.

Gray Oncology Solutions

Pre Seed Round in 2021
Gray Oncology Solutions is a company dedicated to enhancing cancer treatment logistics through innovative resource allocation software. It aims to create a personalized oncology workflow that optimizes each patient's journey, ensuring statistically improved clinical outcomes. The company develops an operating system that streamlines workflows for various oncological interventions, automates patient scheduling, and incorporates complex multidisciplinary processes. By focusing on the functional efficiency of cancer centers, Gray Oncology Solutions seeks to reduce patient wait times, improve access to care, and elevate both patient and staff satisfaction, ultimately leading to superior patient care.

Allevi

Venture Round in 2018
Allevi is a pioneering company that develops innovative tools for designing and engineering 3D tissues. It specializes in desktop 3D bioprinters capable of creating functional, three-dimensional living tissues, alongside proprietary bioinks composed of collagen and hyaluronic acid. Allevi's cloud-based platform, Bioprint Online, allows users to design structures, select materials, and monitor the printing process. Its products cater to a diverse clientele, including researchers in tissue engineering, regenerative medicine, material science, and cell biology, as well as industrial and pharmaceutical companies involved in drug testing and development. Additionally, Allevi sells its bioinks online. Founded in 2014 and headquartered in Philadelphia, Pennsylvania, the company was previously known as BioBots, Inc.

StageMark

Series B in 2007
StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.